Zynex, Inc. (NASDAQ:ZYXI) CFO Sells $71,500.00 in Stock

Zynex, Inc. (NASDAQ:ZYXI) CFO Daniel J. Moorhead sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $7.15, for a total transaction of $71,500.00. Following the completion of the transaction, the chief financial officer now owns 10,050 shares of the company’s stock, valued at approximately $71,857.50. This trade represents a 49.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Zynex Trading Up 1.1 %

Shares of ZYXI stock opened at $7.35 on Friday. Zynex, Inc. has a 1-year low of $7.00 and a 1-year high of $13.19. The company has a current ratio of 3.94, a quick ratio of 3.15 and a debt-to-equity ratio of 1.66. The stock has a market cap of $234.07 million, a price-to-earnings ratio of 49.00 and a beta of 0.81. The stock has a 50-day moving average of $7.75 and a 200-day moving average of $8.02.

Institutional Trading of Zynex

Institutional investors have recently added to or reduced their stakes in the stock. Hotchkis & Wiley Capital Management LLC boosted its stake in shares of Zynex by 24.7% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 746,380 shares of the company’s stock valued at $6,090,000 after purchasing an additional 147,770 shares during the last quarter. GSA Capital Partners LLP lifted its holdings in Zynex by 72.7% in the third quarter. GSA Capital Partners LLP now owns 79,930 shares of the company’s stock valued at $652,000 after buying an additional 33,649 shares during the period. Lido Advisors LLC bought a new stake in Zynex during the fourth quarter valued at $240,000. Geode Capital Management LLC grew its holdings in Zynex by 6.7% during the 3rd quarter. Geode Capital Management LLC now owns 425,509 shares of the company’s stock worth $3,473,000 after acquiring an additional 26,774 shares during the period. Finally, Janney Montgomery Scott LLC grew its holdings in Zynex by 22.3% during the 3rd quarter. Janney Montgomery Scott LLC now owns 144,439 shares of the company’s stock worth $1,179,000 after acquiring an additional 26,368 shares during the period. 29.68% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reissued a “buy” rating and issued a $17.00 price objective on shares of Zynex in a research note on Friday, December 6th.

About Zynex

Zynex, Inc, together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device.